More Immutep Ltd news Immutep LtdASX: IMM US FDA & IRB approves start of ph2b head & neck cancer trial Jul 6, 2021 at 3:18 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
